Evidence map›Paper›PMID 36350273›Full record

ArticleJournal of applied clinical medical physics2023

On the feasibility of improved target coverage without compromising organs at risk using online adaptive stereotactic partial breast irradiation (A-SPBI).

Steven K Montalvo, Nathan Kim, Chika Nwachukwu, Prasanna Alluri, David Parsons, Mu-Han Lin, Bin Cai, Tingliang Zhuang, Brian Hrycushko, Liyuan Chen and 2 more

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Steven K MontalvoDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Nathan KimDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Chika NwachukwuDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Prasanna AlluriDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
David ParsonsDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Mu-Han LinDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Bin CaiDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Tingliang ZhuangDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Brian HrycushkoDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Liyuan ChenDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Robert TimmermanDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.
Asal RahimiDepartment of Radiation Oncology, UT Southwestern Harold C. Simmons Cancer Center, Dallas, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDescribe an early-adopting institution's experience with online adaptive radiation for stereotactic partial breast irradiation. METHODS AND MATERIALS: Retrospective review of 22 women treated between May 2021 and March 2022 with adaptive stereotactic partial breast irradiation. A total of 106 of 110 fractions were evaluated for dosimetric changes in target coverage and organ-at-risk (OAR) dose. Patient set up with stereotactic wooden frame and adapted per fraction. Treatment and planning times were collected prospectively by radiation therapists.

resultsScheduled PTV

conclusionsAdaptive stereotactic breast irradiation resulted in improved target coverage with equivalent dosing to OARs in an efficient and tolerated treatment time. Improved target coverage allowed for decreased PTV margins compared to prior trial protocols that may improve acute and late toxicities.

Indexed as

Organs at RiskRadiosurgeryFeasibility StudiesFemaleHumansRadiotherapy DosageRadiotherapy Planning, Computer-Assistedadaptivepartial breast irradiationstereotactic

Identifiers

PMID36350273
PMCPMC9924103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.